Health officials in Montana confirmed the state's first-ever case of the fungal infection Candida auris this week.The fungal ...

This may include oral antifungal medications. However, this is an emerging illness, and large studies on the best treatment are unavailable. The same 2024 CDC report indicates the use of ...

According to a new study published on Thursday in the journal Science, young salmon exposed to anti-anxiety drugs in the water made it past dams faster. But ecologists are doubtful that it means a ...

Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access to GLP-1 medications, such as Ozempic and Wegovy, for millions of ...

Crop spraying in the United States could make a £250 million antifungal drug ineffective before it even reaches the market, experts have warned. Researchers at the University of Manchester have ...

As with antibiotics, controlling the use of fungicides in agriculture is seen as key to fending off the rising threat of antimicrobial resistance - iStockphoto ...

India's anti-obesity drug market has surged, growing over fourfold in five years, reaching ₹576 crore by March 2025, driven by lifestyle diseases and increased affordability. Semaglutide, particularly ...

Abu Dhabi Police’s “Secret Hideouts” operation seizes 184kg of drugs Abu Dhabi police warn against increasing use of social media platforms by international drug traffickers. Photo for ...

I RECEIVED a letter from CVS Caremark informing me that effective March 1st, HealthTrust would no longer cover anti-obesity medications for my patients who have the HealthTrust prescription ...

Prescription weight loss medications, including GLP-1 agonists, orlistat, and Contrave, may be effective for some people. But other lifestyle changes are still necessary for long-term success.

The gov­ern­ment said it “may con­sid­er fu­ture pol­i­cy op­tions” for an­ti-obe­si­ty med­ica­tions, af­ter de­clin­ing to fi­nal­ize a Biden-era pro­pos­al that would ...

The number of prescriptions for the drugs increased by more than 400% during that same time period. The average annual cost per patient for a GLP-1 drug is $12,000, according to a Peterson-KFF ...